BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
34 results:

  • 1. Testosterone replacement therapy: clinical considerations.
    Luther PM; Spillers NJ; Talbot NC; Sinnathamby ES; Ellison D; Kelkar RA; Ahmadzadeh S; Shekoohi S; Kaye AD
    Expert Opin Pharmacother; 2024; 25(1):25-35. PubMed ID: 38229462
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular characterization of large cell calcifying sertoli cell tumors: A multi-institutional study of 6 benign and 2 malignant tumors.
    Abdulfatah E; Al-Obaidy KI; Robinson D; Wu YM; Heider A; Idrees MT; Ulbright TM; Kunju LP; Wu A
    Hum Pathol; 2024 Feb; 144():15-21. PubMed ID: 38154678
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
    Deng L; Zeng J; Qiu JF; Yang LH; Ma J
    Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial.
    Jørgensen PL; Kreiberg M; Jørgensen N; Juul A; Oturai PS; Dehlendorff C; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Medici CR; Jørgensen NR; Bandak M
    Acta Oncol; 2023 Jul; 62(7):689-695. PubMed ID: 37151105
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular Correlates of Aggressive Behavior and Biological Progression in testicular Sertoli Cell Tumors.
    Rizzo NM; Sholl LM; Kao CS; Cornejo KM; Sangoi AR; Hirsch MS; Collins K; Gordetsky JB; Reyes Curcio FA; Fletcher CDM; Ulbright TM; Acosta AM
    Mod Pathol; 2023 Jul; 36(7):100152. PubMed ID: 36906070
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
    Takamochi K; Tsuboi M; Okada M; Niho S; Ishikura S; Oyamada S; Yamaguchi T; Suzuki K;
    Ann Surg Oncol; 2022 Dec; 29(13):8198-8206. PubMed ID: 36097299
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
    Kreiberg M; Jørgensen N; Juul A; Lauritsen J; Oturai P; Helge JW; Christensen JF; Aksglaede L; Schauer T; Wagner T; Rosenvilde J; Grunwald E; Dehlendorff C; Daugaard G; Bandak M
    Clin Genitourin Cancer; 2022 Oct; 20(5):404-414. PubMed ID: 35701334
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effect of Testosterone Replacement Therapy on Quality of Life and Sexual Function in testicular cancer Survivors With Mild Leydig Cell Insufficiency: Results From a Randomized Double-blind Trial.
    Højer EG; Kreiberg M; Dehlendorff C; Jørgensen N; Juul A; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Bandak M
    Clin Genitourin Cancer; 2022 Aug; 20(4):334-343. PubMed ID: 35514022
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Role of Testosterone in the Elderly: What Do We Know?
    Barone B; Napolitano L; Abate M; Cirillo L; Reccia P; Passaro F; Turco C; Morra S; Mastrangelo F; Scarpato A; Amicuzi U; Morgera V; Romano L; Calace FP; Pandolfo SD; De Luca L; Aveta A; Sicignano E; Trivellato M; Spena G; D'Alterio C; Fusco GM; Vitale R; Arcaniolo D; Crocetto F
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408895
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predicted leukocyte telomere length and risk of germ cell tumours.
    Cigan SS; Meredith JJ; Kelley AC; Yang T; Langer EK; Hooten AJ; Lane JA; Cole BR; Krailo M; Frazier AL; Pankratz N; Poynter JN
    Br J Cancer; 2022 Jul; 127(2):301-312. PubMed ID: 35368045
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. tert Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors.
    Kruslin B; Gatalica Z; Hes O; Skenderi F; Miettinen M; Contreras E; Xiu J; Ellis M; Florento E; Vranic S; Swensen J
    Clin Genitourin Cancer; 2021 Aug; 19(4):333-338. PubMed ID: 33741265
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular signatures identified by integrating gene expression and methylation in non-seminoma and seminoma of testicular germ cell tumours.
    Mallik S; Qin G; Jia P; Zhao Z
    Epigenetics; 2021; 16(2):162-176. PubMed ID: 32615059
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Distinct telomere length and molecular signatures in seminoma and non-seminoma of testicular germ cell tumor.
    Sun H; Kim P; Jia P; Park AK; Liang H; Zhao Z
    Brief Bioinform; 2019 Jul; 20(4):1502-1512. PubMed ID: 29579225
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of tert by ZNF148.
    Fang J; Jia J; Makowski M; Xu M; Wang Z; Zhang T; Hoskins JW; Choi J; Han Y; Zhang M; Thomas J; Kovacs M; Collins I; Dzyadyk M; Thompson A; O'Neill M; Das S; Lan Q; Koster R; ; ; ; Stolzenberg-Solomon RS; Kraft P; Wolpin BM; Jansen PWTC; Olson S; McGlynn KA; Kanetsky PA; Chatterjee N; Barrett JH; Dunning AM; Taylor JC; Newton-Bishop JA; Bishop DT; Andresson T; Petersen GM; Amos CI; Iles MM; Nathanson KL; Landi MT; Vermeulen M; Brown KM; Amundadottir LT
    Nat Commun; 2017 May; 8():15034. PubMed ID: 28447668
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. 'Forever Young'-Testosterone replacement therapy: a blockbuster drug despite flabby evidence and broken promises.
    Busnelli A; Somigliana E; Vercellini P
    Hum Reprod; 2017 Apr; 32(4):719-724. PubMed ID: 28333214
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hotspot tert promoter mutations are rare events in testicular germ cell tumors.
    Cárcano FM; Vidal DO; van Helvoort Lengert A; Neto CS; Queiroz L; Marques H; Baltazar F; da Silva Martinelli CM; Soares P; da Silva EC; Lopes LF; Reis RM
    Tumour Biol; 2016 Apr; 37(4):4901-7. PubMed ID: 26526580
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tubular ectasia of the rete testis (tert). Differential diagnosis of cystic testicular disorders.
    Mahlknecht A; Mahlknecht P; Fallaha M; Wieser A
    Arch Ital Urol Androl; 2015 Mar; 87(1):5-7. PubMed ID: 25847888
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis.
    Elzinga-Tinke JE; Dohle GR; Looijenga LH
    Asian J Androl; 2015; 17(3):381-93. PubMed ID: 25791729
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic changes in nonepithelial ovarian cancer.
    Van Nieuwenhuysen E; Lambrechts S; Lambrechts D; Leunen K; Amant F; Vergote I
    Expert Rev Anticancer Ther; 2013 Jul; 13(7):871-82. PubMed ID: 23875665
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.
    Ruark E; Seal S; McDonald H; Zhang F; Elliot A; Lau K; Perdeaux E; Rapley E; Eeles R; Peto J; Kote-Jarai Z; Muir K; Nsengimana J; Shipley J; ; Bishop DT; Stratton MR; Easton DF; Huddart RA; Rahman N; Turnbull C
    Nat Genet; 2013 Jun; 45(6):686-9. PubMed ID: 23666240
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.